Nutriband: U.S. Patent for Transdermal Abuse Deterrent Tech

 Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that the United States Patent and Trademark Office (USPTO) has granted US Patent No. 11,759,431 for Nutriband's proprietary AVERSA™ abuse deterrent technology utilizing taste aversion to address the primary routes of abuse of opioid based transdermal patches.

https://www.biospace.com/article/releases/nutriband-announces-issuance-of-u-s-patent-for-transdermal-abuse-deterrent-technology/